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Background:  
Routine screening for lung cancer in high risk groups (characterised by age and smoking 
history) is recommended in the USA and may be implemented elsewhere. It is unclear 
whether being screened for lung cancer promotes smoking cessation or conversely 
provides false reassurance and a ‘license to smoke’. This study aimed to understand how 
experiences of lung cancer screening influence individual decision making about 
smoking. 
 
Methods: 
Thirty one people in Scotland, aged 51–74, took part in semi-structured interviews. They 
had been screened with the EarlyCDT-Lung Test (13 positive result; 18 negative) as part 
of the Early Cancer Detection Test–Lung Cancer Scotland (ECLS) Study and were long-
term smokers when screened. Verbatim transcripts were analysed using thematic 
analysis. 
 
Results: 
Interpretations of test results was a key theme, but were often inaccurate, for example a 
negative result interpreted as an ‘all-clear’ from lung cancer and a positive result as 
meaning lung cancer will definitely develop. There was no clear pattern in decisions 
made about smoking in response to positive or negative test results. Emotional response 
to those interpretations was an overarching theme in decisions about smoking. Emotions 
included fear, shock, upset, worry, anxiety, guilt, relief, reassurance and indifference. 
Other themes included changes in perceived risk of smoking-related disease, a feeling 
that now is the time to stop smoking, interpersonal family influences and avoidance of 
thoughts about smoking. Of those who had stopped smoking, some cited screening 
experiences as the sole reason and some cited screening along with other coinciding 
factors. Cues to change were experienced at different stages of the screening process 
and not always immediately following a test result. Some participants indicated they 
underwent screening in order to try and stop smoking. Others expressed little or no 
desire to stop. In general, lung cancer screening was experienced as a unique 
opportunity, which sometimes prompted successful or unsuccessful attempts to stop 
smoking. 
 
Conclusion: 
Lung cancer screening can be a ‘teachable moment’ for smoking behaviour change. 
Emotional responses to test results, which can be misinterpreted, were an important 
theme but behavioural responses varied according to the individual. Findings should be 
considered within the context of a group of predominantly life-long smokers undergoing 
a novel blood screening test, who might already have increased motivation to stop 
smoking. Lung cancer screening presents an opportunity to engage high risk smokers in 
cessation support but our findings suggest such support may need to be available 
flexibly to be most effective. 
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